The Cooper Companies, Inc. (COO) Q4 2025 Earnings Call Transcript
The headline numbers for The Cooper Companies (COO) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
The Cooper Companies (COO) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.04 per share a year ago.
| - Industry | - Sector | Albert G. White III CEO | XFRA Exchange | US2166485019 ISIN |
| US Country | 16,000 Employees | 26 Jul 2023 Last Dividend | 20 Feb 2024 Last Split | - IPO Date |
The Cooper Companies, Inc., established in 1958 and headquartered in San Ramon, California, is a global entity that specializes in the development, manufacture, and marketing of contact lenses through its subsidiaries. The operations of the company are segmented into CooperVision and CooperSurgical. CooperVision focuses on providing a variety of contact lenses including those for correcting nearsightedness, farsightedness, astigmatism, presbyopia, and myopia across various regions such as the Americas, Europe, Middle East, Africa, and Asia Pacific. On the other hand, CooperSurgical addresses family and women's health, offering a wide range of fertility products and services, medical devices, contraception, and cryostorage services for cord blood and tissue to healthcare professionals and patients globally. The products offered by The Cooper Companies, Inc. reach their end-users through distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals, clinics, and authorized resellers.
CooperVision:
CooperSurgical: